UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049170
Receipt number R000055982
Scientific Title Assessments of intraoperative flow cytometer
Date of disclosure of the study information 2022/10/10
Last modified on 2024/04/11 13:03:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Assessments of the new cutoff value and the accuracy of Intraoperative flow cytometer for the intraoperative frozen section diagnosis and the intraoperative frozen section diagnosis of the resection margin in malignant brain tumor surgery

Acronym

Assessments of intraoperative flow cytometer

Scientific Title

Assessments of intraoperative flow cytometer

Scientific Title:Acronym

IFC-A

Region

Japan


Condition

Condition

Malignant Brain Tumor

Classification by specialty

Neurosurgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To confirm the accuracy of the intraoperative flow cytometer in surgical explanted specimens, we will compare the accuracy of the intraoperative frozen diagnosis by pathology with that of the intraoperative frozen section of tumor marginal specimens.

Basic objectives2

Others

Basic objectives -Others

Accuracy verification

Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

calculation of malignant index level

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Intraoperative flow cytometer

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) All patients with gliomas (benign and malignant), metastatic brain tumors, and other malignant brain tumors who undergo surgery in our department.
2) Patients of any age and gender.
3) Written consent to participate in the study must be obtained from the patient or a substitute author.

Key exclusion criteria

1) Patients with a preoperative diagnosis of a non-glioma benign brain tumor.
2) For tumors of obvious intraventricular origin with minimal intracerebral attachment.
3) For tumors within the brain trunk.
4) In the case of tumors in the mesencephalic/pituitary region.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Kenichiroh
Middle name
Last name Asano

Organization

Hirosaki University Graduate School of Medicine

Division name

Neurosurgery

Zip code

036-8562

Address

Zaifu-cho 5, Hirosaki-shi, Aomori Prefecture, 036-8562, Japan

TEL

0172-39-5115

Email

asanoken@hirosaki-u.ac.jp


Public contact

Name of contact person

1st name Kenichiroh
Middle name
Last name Asano

Organization

Hirosaki University Graduate School of Medicine

Division name

Neurosurgery

Zip code

036-8562

Address

Zaifu-cho 5, Hirosaki-shi, Aomori Prefecture, 036-8562, Japan

TEL

0172-39-5115

Homepage URL

https://hirosaki-u-neuros.jp

Email

asanoken@hirosaki-u.ac.jp


Sponsor or person

Institute

Hirosaki University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Hirosaki University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Nihon Kohden

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hirosaki University Graduate School of Medicine

Address

Zaifu-cho 5, Hirosaki-shi, Aomori Prefecture, 036-8562, Japan

Tel

0172-33-5111

Email

rinri@hirosaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 10 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2020 Year 04 Month 01 Day

Date of IRB

2020 Year 05 Month 22 Day

Anticipated trial start date

2020 Year 05 Month 22 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 10 Month 10 Day

Last modified on

2024 Year 04 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000055982


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name